Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors

• Үндсэн зохиолчид: Mark G. Kirchhof (Зохиогч), Vimal H. Prajapati (Зохиогч), Melinda Gooderham (Зохиогч), Chih-ho Hong (Зохиогч), Charles W. Lynde (Зохиогч), Catherine Maari (Зохиогч), Irina Turchin (Зохиогч), Kim A. Papp (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Adis, Springer Healthcare, 2024-08-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy, have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic dermatitis (AD). Like other small molecules, oral JAKi have the potential for off-target effects including laboratory-relat...